Opioid Settlement Controversy

A deep dive into the Sacklers' controversial $6 billion opioid settlement reveals their strategic maneuvering to escape accountability for the opioid crisis. The Supreme Court's recent decision to pause the settlement opens the door for potential further legal repercussions, challenging the Sacklers' financial safety net. Insights into the moral implications of their actions highlight the stark contrast between capitalism and ethics in the pharmaceutical industry.